TTK Healthcare Limited is an India-based company providing consumer and healthcare products. The Company's segments include Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others. The Animal Welfare segment offers products for veterinary use, including the brands Ossomin, Orcal-P, Epidosin, and others. The Consumer Products segment markets and distributes Woodward's Gripe Water, the EVA range of cosmetics, the Good Home range of scrubbers, air fresheners, and various other products. The Medical Devices segment includes the manufacturing and marketing of artificial heart valves, orthopedic implants, and others. The Protective Devices segment focuses on manufacturing and marketing male contraceptives and related products. The Foods segment involves the manufacturing and marketing of food products. Extruded products, such as papads, are offered under the brand name Fryums. The Others segment includes the printing and publishing of maps and atlases.
TTK Healthcare Financial Highlights
- Revenue: TTK Healthcare reported revenue of ₹929.43 crore in FY26 vs ₹872.74 crore in FY25. It showed an increase of 6.50% on a yearly basis.
- Operating Profit: TTK Healthcare reported an operating profit of ₹82.56 crore in FY26 vs ₹108.33 crore in FY25. It showed a decrease of 23.79% on a year-on-year basis.
- Net Profit: TTK Healthcare reported a net profit of ₹65.68 crore in FY26 vs ₹81.66 crore in FY25. It showed a decrease of 19.57% on a yearly basis.
TTK Healthcare Quarterly Result Highlights
- TTK Healthcare reported revenue of ₹235.75 crore in Mar 2026, compared with ₹226.73 crore in Dec 2025, representing an increase of 3.98% on a quarter-on-quarter (QoQ) basis.
- TTK Healthcare reported an operating profit of ₹29.53 crore in Mar 2026, compared with ₹14.09 crore in Dec 2025, representing an increase of 109.58% on a quarter-on-quarter (QoQ) basis.
- TTK Healthcare reported a profit of ₹21.76 crore in Mar 2026, compared with ₹10.53 crore in Dec 2025, reflecting an increase of 106.65% on a QoQ basis.
- The earnings per share (EPS) of TTK Healthcare stood at ₹46.48 during Mar 2026.